Cubist Systematic Strategies, LLC Deciphera Pharmaceuticals, Inc. Transaction History

Cubist Systematic Strategies, LLC

$14.3 Billion
Q2 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$13.58 - $17.36 $373,395 - $477,330	-27,496 Reduced 9.88%	250,889 $3.95 Million
Q4 2023 Feb 14, 2024	BUY	$10.11 - $16.54 $594,073 - $971,906	58,761 Added 26.76%	278,385 $4.49 Million
Q3 2023 Nov 14, 2023	BUY	$12.46 - $15.48 $2.74 Million - $3.4 Million	219,624 New	219,624 $2.79 Million
Q1 2023 May 15, 2023	SELL	$14.26 - $22.1 $166,499 - $258,039	-11,676 Reduced 8.64%	123,486 $1.91 Million
Q4 2022 Feb 14, 2023	SELL	$14.85 - $19.04 $2.7 Million - $3.46 Million	-181,551 Reduced 57.32%	135,162 $2.22 Million
Q3 2022 Nov 14, 2022	BUY	$12.38 - $20.23 $1.69 Million - $2.76 Million	136,570 Added 75.81%	316,713 $5.86 Million
Q2 2022 Aug 15, 2022	BUY	$9.11 - $13.98 $418,185 - $641,737	45,904 Added 34.2%	180,143 $2.37 Million
Q1 2022 May 16, 2022	SELL	$6.87 - $11.11 $122,231 - $197,669	-17,792 Reduced 11.7%	134,239 $1.24 Million
Q4 2021 Feb 14, 2022	BUY	$7.7 - $37.13 $979,255 - $4.72 Million	127,176 Added 511.67%	152,031 $1.49 Million
Q3 2021 Nov 15, 2021	BUY	$26.46 - $37.15 $654,011 - $918,236	24,717 Added 17910.87%	24,855 $845,000
Q2 2021 Aug 16, 2021	SELL	$32.73 - $47.95 $235,557 - $345,096	-7,197 Reduced 98.12%	138 $5,000
Q1 2021 May 17, 2021	SELL	$40.39 - $56.73 $580,363 - $815,153	-14,369 Reduced 66.2%	7,335 $329,000
Q4 2020 Feb 16, 2021	BUY	$51.77 - $66.18 $406,498 - $519,645	7,852 Added 56.68%	21,704 $1.24 Million
Q3 2020 Nov 16, 2020	BUY	$43.8 - $58.16 $440,277 - $584,624	10,052 Added 264.53%	13,852 $711,000
Q2 2020 Aug 14, 2020	SELL	$37.05 - $65.03 $535,224 - $939,423	-14,446 Reduced 79.17%	3,800 $227,000
Q1 2020 May 15, 2020	SELL	$33.63 - $69.4 $2.11 Million - $4.35 Million	-62,705 Reduced 77.46%	18,246 $751,000
Q4 2019 Feb 14, 2020	BUY	$31.7 - $69.93 $2.53 Million - $5.58 Million	79,751 Added 6645.92%	80,951 $5.04 Million
Q3 2019 Nov 14, 2019	SELL	$19.95 - $38.85 $246,641 - $480,302	-12,363 Reduced 91.15%	1,200 $41,000
Q2 2019 Aug 14, 2019	BUY	$21.05 - $26.21 $102,176 - $127,223	4,854 Added 55.74%	13,563 $306,000
Q1 2019 May 15, 2019	SELL	$20.65 - $29.55 $255,316 - $365,356	-12,364 Reduced 58.67%	8,709 $202,000
Q4 2018 Feb 14, 2019	BUY	$19.08 - $36.14 $402,072 - $761,578	21,073 New	21,073 $442,000

Others Institutions Holding DCPH

# of Institutions

Shares Held

343K

Call Options Held

500

Put Options Held

View Full List

About Deciphera Pharmaceuticals, Inc.

Ticker DCPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,822,100
Description
Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gas...

More about DCPH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.

Account